It's getting out that Aristotle has OUTGROWN Care Oncology
This is what we're acquiring, folks!
A successful, international telehealth oncology-support system that has shown marked results in patient survivability.for glioblastoma (the cell-phone cancer!)
AND SZLS is aggressively expanding the availability of Aristotle in the market, a CLEAR INDICATION that Care Oncology's patient base (who had first dibs on the test) has largely been tested.
Nothing but good news, and a real pie in the face for StageZero's detractors, who, if they sold, are going to have to scurry to rebuild their positions, lol.
I love days like these... *popcorn